Tokyo, June 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000055262) titled 'Investigating the changes in various clinical parameters induced by tirzepatide' on June 1
Study Type:
Observational
Study Design:
Primary Sponser:
Institute - Shinmatsudo Central General Hospital
Condition:
Condition - type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Intervention:
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients were adults aged 20 years or older, diagnosed with type 2 diabetes, who could regularly attend our hospital, with HbA1c below 10.0% and BMI of 23 kg/m2 or higher.
Key exclusion criteria...